M Zouhair Atassi Selected Research

Torticollis (Wryneck)

1/2018	The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
1/2017	Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules.
11/2016	Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
4/2016	Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
4/2015	The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
7/2014	Reduction of established antibody responses against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol peptide conjugates.
1/2012	Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
12/2011	Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
7/2011	Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies.
6/2011	Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Zouhair Atassi Research Topics

Disease

15	Torticollis (Wryneck) 01/2018 - 03/2006
9	Myasthenia Gravis 11/2017 - 05/2002
5	Autoimmune Diseases (Autoimmune Disease) 11/2017 - 03/2005
3	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 09/2017 - 02/2006
2	Movement Disorders (Movement Disorder) 12/2011 - 08/2011
1	Necrosis 09/2017
1	Muscle Spasticity (Spastic) 01/2017
1	Cerebral Palsy (Spastic Diplegia) 01/2017
1	Neuroblastoma 04/2015
1	Paralysis (Palsy) 04/2015
1	Dystonia (Limb Dystonia) 10/2009
1	Inflammation (Inflammations) 03/2008
1	Neoplasms (Cancer) 03/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2008
1	Infections 03/2008
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2007
1	Weight Loss (Weight Reduction) 06/2006
1	Fatigue 06/2006
1	Tremor (Tremors) 06/2006
1	Whooping Cough (Pertussis) 02/2006
1	Hemorrhage 08/2005
1	Hypersensitivity (Allergy) 03/2005
1	Wounds and Injuries (Trauma) 01/2005
1	Tetanus 08/2002

Drug/Important Bio-Agent (IBA)

13	incobotulinumtoxinA FDA Link 01/2018 - 08/2005
8	Botulinum Toxins (Botulinum Toxin)IBA 01/2018 - 08/2002
8	Type A Botulinum Toxins (Botox)FDA Link 01/2018 - 03/2006
7	Peptides (Polypeptides)IBA 01/2018 - 01/2005
7	AntibodiesIBA 04/2015 - 06/2006
5	Cholinergic ReceptorsIBA 03/2012 - 05/2002
3	Blocking AntibodiesIBA 01/2012 - 09/2008
2	AntigensIBA 01/2018 - 01/2007
2	Freund's AdjuvantIBA 09/2017 - 08/2017
2	Immune Sera (Antisera)IBA 07/2011 - 08/2005
2	Proteins (Proteins, Gene)FDA Link 03/2008 - 03/2005
2	EpitopesIBA 03/2008 - 01/2007
2	Histocompatibility Antigens Class IIIBA 01/2007 - 02/2006
1	ThymidineIBA 01/2018
1	tetanospasmin (tentoxilysin)IBA 01/2018
1	Immunoglobulin FragmentsIBA 11/2017
1	AutoantigensIBA 11/2017
1	CytokinesIBA 09/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2015
1	AutoantibodiesIBA 03/2012
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2012
1	Tetanus ToxinIBA 12/2011
1	rimabotulinumtoxinB FDA Link 09/2008
1	Protein Tyrosine PhosphatasesIBA 03/2008
1	Protein SIBA 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008
1	HLA-DQ Antigens (HLA-DQ)IBA 06/2006
1	muskIBA 06/2006
1	Phosphotransferases (Kinase)IBA 06/2006
1	HLA-DQA1 antigen (HLA DQA1)IBA 06/2006
1	ToxoidsIBA 03/2006
1	aluminum sulfate (alum)IBA 02/2006

Therapy/Procedure

3	Injections 09/2017 - 02/2006
1	Resuscitation 01/2005